US Patent

US11896759 — Inhalers and related methods

Formulation · Assigned to Norton Waterford Ltd · Expires 2038-01-26 · 12y remaining

Vulnerability score 38/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects an inhaler design with a lock system for securing the cap housing on the main body.

USPTO Abstract

An inhaler (10) has a main body for accommodating a medicament reservoir (84), a canister fire system for moving a canister (50) to release a dose in response to air flow, a cap housing (12) for enclosing the canister fire system and canister within an interior chamber defined by the main body (14) and a cap housing, wherein a lock system (250) is provided for locking the cap housing on the main body.

Drugs covered by this patent

beclomethasone-dipropionate (BECLOMETHASONE DIPROPIONATE)

Patent Metadata

Patent number: US11896759
Jurisdiction: US
Classification: Formulation
Expires: 2038-01-26
Drug substance claim: No
Drug product claim: Yes
Assignee: Norton Waterford Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.